These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28129464)

  • 1. Relationship between the hippocampal shape abnormality and serum cortisol levels in first-episode and drug-naïve major depressive disorder patients.
    Watanabe R; Kakeda S; Watanabe K; Liu X; Katsuki A; Umeno-Nakano W; Hori H; Abe O; Yoshimura R; Korogi Y
    Depress Anxiety; 2017 May; 34(5):401-409. PubMed ID: 28129464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cortisol on hippocampal subfields volumes and memory performance in healthy control subjects and patients with major depressive disorder.
    Travis SG; Coupland NJ; Hegadoren K; Silverstone PH; Huang Y; Carter R; Fujiwara E; Seres P; Malykhin NV
    J Affect Disord; 2016 Sep; 201():34-41. PubMed ID: 27162154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.
    Liu X; Kakeda S; Watanabe K; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umeno-Nakano W; Watanabe R; Ueda I; Moriya J; Nakamura J; Korogi Y
    Depress Anxiety; 2015 Sep; 32(9):702-8. PubMed ID: 26290363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal subfield analysis in medication-naïve female patients with major depressive disorder.
    Han KM; Won E; Sim Y; Tae WS
    J Affect Disord; 2016 Apr; 194():21-9. PubMed ID: 26802503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal N-acetylaspartate and morning cortisol levels in drug-naive, first-episode patients with major depressive disorder: effects of treatment.
    Wang Y; Jia Y; Chen X; Ling X; Liu S; Xu G; Huang L
    J Psychopharmacol; 2012 Nov; 26(11):1463-70. PubMed ID: 22706518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug-Naïve Patients With Major Depressive Disorder.
    Hu X; Zhang L; Hu X; Lu L; Tang S; Li H; Bu X; Gong Q; Huang X
    J Magn Reson Imaging; 2019 Jun; 49(6):1760-1768. PubMed ID: 30295348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal subfield volumes in major depressive disorder and bipolar disorder.
    Han KM; Kim A; Kang W; Kang Y; Kang J; Won E; Tae WS; Ham BJ
    Eur Psychiatry; 2019 Apr; 57():70-77. PubMed ID: 30721801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural differences in hippocampal subfields among schizophrenia patients, major depressive disorder patients, and healthy subjects.
    Ota M; Sato N; Hidese S; Teraishi T; Maikusa N; Matsuda H; Hattori K; Kunugi H
    Psychiatry Res Neuroimaging; 2017 Jan; 259():54-59. PubMed ID: 27987389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between VEGF-related gene polymorphisms and brain morphology in treatment-naïve patients with first-episode major depressive disorder.
    Nguyen L; Kakeda S; Katsuki A; Sugimoto K; Otsuka Y; Ueda I; Igata R; Watanabe K; Kishi T; Iwata N; Korogi Y; Yoshimura R
    Eur Arch Psychiatry Clin Neurosci; 2019 Oct; 269(7):785-794. PubMed ID: 30406404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between white matter integrity and serum cortisol levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics.
    Liu X; Watanabe K; Kakeda S; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umene-Nakano W; Watanabe R; Ueda I; Nakamura J; Korogi Y
    Br J Psychiatry; 2016 Jun; 208(6):585-90. PubMed ID: 26892846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortisol/DHEA ratio and hippocampal volume: A pilot study in major depression and healthy controls.
    Jin RO; Mason S; Mellon SH; Epel ES; Reus VI; Mahan L; Rosser RL; Hough CM; Burke HM; Mueller SG; Wolkowitz OM
    Psychoneuroendocrinology; 2016 Oct; 72():139-46. PubMed ID: 27428086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hippocampus in Depression: More Than the Sum of Its Parts? Advanced Hippocampal Substructure Segmentation in Depression.
    Roddy DW; Farrell C; Doolin K; Roman E; Tozzi L; Frodl T; O'Keane V; O'Hanlon E
    Biol Psychiatry; 2019 Mar; 85(6):487-497. PubMed ID: 30528746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dentate gyrus volume and memory performance in major depressive disorder.
    Travis S; Coupland NJ; Silversone PH; Huang Y; Fujiwara E; Carter R; Seres P; Malykhin NV
    J Affect Disord; 2015 Feb; 172():159-64. PubMed ID: 25451411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-regional hippocampal volumes in first-episode drug-naïve major depression disorder.
    Liu MN; Pantouw JG; Yang KC; Hu LY; Liou YJ; Lirng JF; Chou YH
    Neurosci Lett; 2021 Oct; 763():136178. PubMed ID: 34416346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural changes in hippocampal subfields in major depressive disorder: a high-field magnetic resonance imaging study.
    Huang Y; Coupland NJ; Lebel RM; Carter R; Seres P; Wilman AH; Malykhin NV
    Biol Psychiatry; 2013 Jul; 74(1):62-8. PubMed ID: 23419546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():534-7. PubMed ID: 24161452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered hippocampal subfield volumes in major depressive disorder with and without anhedonia.
    Wu C; Jia L; Mu Q; Fang Z; Hamoudi HJAS; Huang M; Hu S; Zhang P; Xu Y; Lu S
    BMC Psychiatry; 2023 Jul; 23(1):540. PubMed ID: 37491229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered T2* relaxation time of the hippocampus in major depressive disorder: implications of ultra-high field magnetic resonance imaging.
    Cho ZH; Kim YB; Han JY; Kim NB; Hwang SI; Kim SJ; Cho SJ
    J Psychiatr Res; 2010 Oct; 44(14):881-6. PubMed ID: 20338580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric study.
    Nguyen L; Kakeda S; Watanabe K; Katsuki A; Sugimoto K; Igata N; Shinkai T; Abe O; Korogi Y; Ikenouchi A; Yoshimura R
    Sci Rep; 2020 Dec; 10(1):22096. PubMed ID: 33328539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glucocorticoid inducible genes is associated with reductions in cornu ammonis and dentate gyrus volumes in patients with major depressive disorder.
    Frodl T; Carballedo A; Frey EM; O'Keane V; Skokauskas N; Morris D; Gill M; Hughes MM; Harkin A; Connor T
    Dev Psychopathol; 2014 Nov; 26(4 Pt 2):1209-17. PubMed ID: 25422956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.